Mineralys Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -9 | -8 | ||
EBITDA | -51,752 | -60,095 | -45,159 | -35,354 |
EBIT | -51,767 | -60,106 | -45,168 | -35,362 |
Net Income | -48,946 | -56,342 | -41,014 | -31,508 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -66,843 | -50,223 | -30,146 | -19,198 |
Cash | 114,091 | 97,274 | 67,856 | 90,418 |
Basic Shares | 49,957 | 49,815 | 49,356 | 44,900 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -192,403 | -84,657 | -31,479 | -18,724 |
EBIT | -84,824 | -31,479 | -37,449 | |
Net Income | -177,810 | -71,898 | -29,799 | -19,408 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -166,410 | -81,173 | -29,221 | -14,559 |
Cash | 114,091 | 49,304 | 87,701 | 10,612 |
Basic Shares | 48,539 | 36,188 | 40,856 | 39,056 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.98 |
2024-09-30 | -$1.13 |
2024-06-30 | -$0.83 |
2024-03-31 | -$0.70 |
